PPARA and fatty liver disease: The decrease in hepatic steatosis was accompanied by decreased expression of lipogenic genes, including Srebp1c and stearoyl-CoA desaturase 1 (Scd1) (Figure 5(c)), and increased expression of β-oxidation-related genes, such as Pparα and Cpt-1α (Figure 5(d)).